Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01765530 · ClinicalTrials.gov registry record · NA

Efficacy Study of a Novel Device to Clean the Endotracheal Tube

A NA study, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
74
Enrollment target

NCT01765530: Completed NA study, sponsored by Massachusetts General Hospital.

NCT01765530 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 74 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01765530, a NA study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
74 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the in-vivo efficacy of a novel device (endOclear) for cleaning the endotracheal tube (ETT) lumen from secretions. The investigators hypothesize that a protocol of routine ETT cleaning with endOclear may increase the ETT luminal volume measured at extubation compared to the current standard of care. The device may therefore be clinically useful by better maintaining the ETT original function.

Primary Outcome

The investigators will measure percentage of occlusion determined by the accumulation of secretion within the lumen of each ETT using a high definition Computed Tomography (CT) imaging of the extubated ETTs. The whole ETT will be analyzed through high-definition CT slices. 100% of occlusion means total occlusion of the lumen of the ETT and 0% means absence of any occlusion.

Interventions

  • DEVICE ETT cleaning maneuver

Trial Details

FieldValue
Enrollment Target 74 participants
Start Date 2012-09
Est. Completion 2013-12
Phase NA
Massachusetts General Hospital

2,032 total trials

What the finished NCT01765530 record still lists

NCT01765530 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 1 intervention - of which ETT cleaning maneuver is the first listed.

NCT01765530 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01765530 about?

NCT01765530 is a clinical study titled "Efficacy Study of a Novel Device to Clean the Endotracheal Tube". The purpose of this study is to evaluate the in-vivo efficacy of a novel device (endOclear) for cleaning the endotracheal tube (ETT) lumen from secretions. The investigators hypothesize that a protocol of routine ETT cleaning with endOclear may increase the ETT luminal volume measured at extubation ...

What is the current status of trial NCT01765530?

This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2012-09. Estimated completion is 2013-12.

What interventions are being tested in trial NCT01765530?

The interventions under investigation include: ETT cleaning maneuver (DEVICE).

Who is sponsoring clinical trial NCT01765530?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01765530's enrollment target sits among peer trials

74 1082nd of 2000 higher than 912 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03422731 · 74 participants · Early Phase 1

    Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy

  • NCT03804853 · 74 participants · NA

    Rehabilitation Following Reverse Total Shoulder Arthroplasty

  • NCT04065776 · 74 participants · NA

    Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma

  • NCT04771156 · 74 participants · Phase 4

    Ketorolac in Palatoplasty

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01765530, the US trial registry maintained by the National Library of Medicine. NCT01765530 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.